Ground Level
Biotechnology
Innovations

Accelerating R&D and technology to help millions worldwide live healthier lives

Novel Innovations Made by Doctors at The Ground Level

Since 2014, we have built a robust USPTO patent portfolio dedicated to advancing local anesthetics and periodontal innovations. Our deep expertise centers on the development of next-generation anesthesia drugs and proprietary nanoparticle formulations.

The foundational value of our intellectual property is driven by high barriers to entry, specialized formulation know-how, and strong clinical utility. Backed by solid legal patent protection and positioned within a rapidly expanding global market, we are continuously innovating—most notably with our upcoming, cutting-edge anticancer nanoparticle formulation technologies.

Versatility in Anesthetics Injectons

Local anesthetics are considered some of the safest and most effective drugs used in medicine for pain management.

Our mixing carpule technology makes dental injections low-cost, less painful, faster-acting, and more reliable.

Nanoparticles

Our rapidly developing formulation technology where materials in the nanoscale range are employed to serve as means of delivering therapeutic agents to specific targeted sites in a controlled manner.

First-of-its-kind Periodontal Device

We can’t ignore the fact that across the globe, periodontitis is the single most prevalent chronic infectious disease.

Our novel periodontal methods and system are expected to reshape nearly every aspect of localized periodontal therapy with the potential to significantly impact the global market.

Nanoparticle Formulation Platform

Prefilled & Disposable Medical Device Solutions

At PharmaPhD, we engineer targeted solutions for niche dental and medical markets characterized by significant unmet clinical needs. To stand apart in a competitive landscape, our pipeline features unique product candidates pursuing novel indications and unprecedented labeling claims. Since our founding in 2014, we have dedicated our resources exclusively to high-impact research and development, driving breakthroughs across advanced periodontal care, next-generation anesthetics, nanoparticle drug formulations, and prefilled medical devices.

Learn More

We Take Pride in Our Numbers & Technology

Years of Experience

Finished Products

Candidate Products

FDA Clearance

50+

Patents & Claims

Our niche markets

Local Anesthetic market

Nano-particle Market

Periodontal Market

Prefilled Syringes Market

Our latest growth

To support expanding domestic and international markets, we are scaling our Florida-based cleanroom manufacturing capacity.

Concurrently, we are on track to receive FDA approval for our two lead finished drug products in 2027.

Driven by novel innovations made by doctors at the ground level, our dedicated R&D team applies advanced science and technology to solve complex health challenges. Led by Ph.D. scientists and clinical experts, our research focuses on discovering novel treatments and optimizing medical devices to directly improve patient outcomes and elevate clinical accuracy.

PharmaPhD’s proprietary prefilled syringe portfolio is purpose-built for our advanced R&D initiatives. We design specialized, customized syringes with the structural variety required to deliver complex therapeutics. Our focus spans high-impact clinical applications, including local anesthesia, periodontal therapeutics, and anticancer nanoparticles for oncology.

To secure our leadership in key medical and dental specialties, PharmaPhD has built a robust intellectual property foundation. We protect the resilience of our products through a comprehensive and growing portfolio of domestic and international patents.

We understand FDA legislative issues, but more importantly, we keep up to date on various policy

Navigating current FDA legislation is the baseline; actively anticipating shifts in regulatory policy is our strategic advantage. By embedding real-time policy intelligence into comprehensive regulatory strategies for all our products and pipeline candidates, we can accurately forecast agency expectations, evaluate hurdles, and proactively address challenges early in development.

Our strategic master plans guide our entire operation. Because they are informed by the latest regulatory shifts, these dynamic documents directly drive our drug and medical device development, ensuring that design requirements and budgets remain perfectly aligned with both current laws and emerging FDA guidelines from day one.

Understanding the evolving landscape of clinical requirements, commercial claims, and accelerated regulatory pathways is critical to our success. This continuous regulatory foresight allows us to design highly efficient development pathways, accurately assess product value, and strategically plan our milestones ahead of future financing or strategic partnerships.

Our Innovations

Our Story

Ground Level Biotechnology Innovations